Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.65 |
| ▸ | PARP3 | Q9Y6F1 | 1/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.64 |
| ▸ | CYP2A6 | P11509 | 3/20 | 0.64 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.61 |
| ▸ | LMNA | P02545 | 2/20 | 0.61 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.61 |
| ▸ | ALDH1A3 | P47895 | 1/20 | 0.56 |
| ▸ | STS | P08842 | 1/20 | 0.54 |
| ▸ | DRD1 | P21728 | 1/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
| ▸ | ALDH5A1 | P51649 | 1/20 | 0.50 |
| ▸ | ABAT | P80404 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | CASP6 | P55212 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.45 |
| ▸ | HPGD | P15428 | 1/20 | 0.45 |
| ▸ | TYR | P14679 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1663469 | 1.00 | PARP10 (0.65) | PARP10PARP3ALDH1A1CYP2A6KDM4E | |
| SCHEMBL97639 | 0.90 | ALDH1A1 (0.59) | PARP10PARP3ALDH1A1CYP2A6KDM4E | |
| SCHEMBL888020 | 0.90 | ALDH1A1 (0.59) | PARP10PARP3ALDH1A1CYP2A6KDM4E | |
| SCHEMBL2267829 | 0.88 | HSD17B10 (0.73) | PARP10PARP3ALDH1A1CYP2A6KDM4E | |
| SCHEMBL260405 | 0.88 | CYP2A6 (0.73) | PARP10PARP3ALDH1A1CYP2A6KDM4E | |
| SCHEMBL23975504 | 0.88 | CYP2A6 (0.73) | PARP10PARP3ALDH1A1CYP2A6KDM4E | |
| SCHEMBL9797690 | 0.88 | PARP10 (0.55) | PARP10PARP3ALDH1A1CYP2A6KDM4E | |
| SCHEMBL184204 | 0.88 | ALDH1A1 (0.62) | PARP10PARP3ALDH1A1CYP2A6KDM4E | |
| SCHEMBL14449279 | 0.88 | PARP10 (0.55) | PARP10PARP3ALDH1A1CYP2A6KDM4E | |
| SCHEMBL3648611 | 0.88 | ALDH1A1 (0.64) | PARP10PARP3ALDH1A1CYP2A6KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025110215-A1 | CURABLE COMPOSITION, COMPOUND, HEAT-RESISTANT RESIN MATERIAL, ADHESIVE, SEALING MATERIAL, POTTING AGENT, ENCAPSULANT, CARBON MATERIAL, AND PREPREG | セメダイン株式会社 | 2025-05-30 | — | — | WO | disclosed |
| US-11542397-B2 | Liquid composition, quantum dot-containing film, optical film, light-emitting display element panel, and light-emitting display device | TOKYO OHKA KOGYO CO., LTD. (JP) | 2023-01-03 | — | — | US | disclosed |
| US-20210309866-A1 | LIQUID COMPOSITION, QUANTUM DOT-CONTAINING FILM, OPTICAL FILM, LIGHT-EMITTING DISPLAY ELEMENT PANEL, AND LIGHT-EMITTING DISPLAY DEVICE | TOKYO OHKA KOGYO CO., LTD. (JP) | 2021-10-07 | — | — | US | disclosed |
| EP-3812805-A1 | LIQUID COMPOSITION, QUANTUM DOT-CONTAINING FILM, OPTICAL FILM, LUMINESCENT DISPLAY ELEMENT PANEL, AND LUMINESCENT DISPLAY DEVICE | TOKYO OHKA KOGYO CO., LTD. (JP) | 2021-04-28 | — | — | EP | disclosed |
| US-10696845-B2 | Energy-sensitive resin composition | TOKYO OHKA KOGYO CO., LTD. (JP) | 2020-06-30 | — | — | US | disclosed |
| US-10570269-B2 | Composition containing microparticles | TOKYO OHKA KOGYO CO., LTD. (JP) | 2020-02-25 | — | — | US | disclosed |
| EP-3275940-B1 | ENERGY-SENSITIVE RESIN COMPOSITION | TOKYO OHKA KOGYO CO LTD (JP) | 2019-12-18 | — | — | EP | disclosed |
| US-20190225804-A1 | ENERGY-SENSITIVE RESIN COMPOSITION | TOKYO OHKA KOGYO CO., LTD. (JP) | 2019-07-25 | — | — | US | disclosed |
| US-10023540-B2 | Hydrogen barrier agent, hydrogen barrier film forming composition, hydrogen barrier film, method for producing hydrogen barrier film, and electronic element | TOKYO OHKA KOGYO CO., LTD. (JP) | 2018-07-17 | — | — | US | disclosed |
| US-20180194930-A1 | COMPOSITION CONTAINING MICROPARTICLES | TOKYO OHKA KOGYO CO., LTD. (JP) | 2018-07-12 | — | — | US | disclosed |
| US-20030143480-A1 | For forming protective film or an insulating film for a semiconductor element or a circuit board such as a printed board | KANSAI PAINT CO., LTD. (JP) | 2003-07-31 | — | — | US | disclosed |
| EP-0597102-B1 | NOVEL BISHETEROCYCLIC DERIVATIVE OR SALT THEREOF AND HYPOGLYCEMIC COMPOSITION | YAMANOUCHI PHARMA CO LTD (JP) | 1999-01-07 | — | — | EP | disclosed |
| US-5508296-A | HYPOGLYCEMIC AGENTS | YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) | 1996-04-16 | — | — | US | disclosed |
| US-5374706-A | High molecular weight ordered polybenzoxazole fibers | THE DOW CHEMICAL COMPANY (US) | 1994-12-20 | — | — | US | disclosed |
| EP-0597102-A1 | NOVEL BISHETEROCYCLIC DERIVATIVE OR SALT THEREOF | YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) | 1994-05-18 | — | — | EP | disclosed |
| US-5053555-A | Flexible spacers in liquid crystalline aromatic polyesters | GENERAL ELECTRIC COMPANY (US) | 1991-10-01 | — | — | US | disclosed |
| US-4873371-A | REACTING A DIHYDROXYAROMATIC COMPOUND WITH AN ARYLCARBONYL COMPOUND, OXIDATION, HYDROLYSIS | GENERAL ELECTRIC COMPANY (US) | 1989-10-10 | — | — | US | disclosed |
| US-4533692-A | Liquid crystalline polymer compositions, process, and products | SRI INTERNATIONAL (US) | 1985-08-06 | — | — | US | disclosed |
| US-4533724-A | Liquid crystalline poly (2,6-benzothiazole) compositions, process, and products | SRI INTERNATIONAL (US) | 1985-08-06 | — | — | US | disclosed |
| US-4533693-A | ANISOTROPIC; FIBERS, FILMS | SRI INTERNATIONAL (US) | 1985-08-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180194930-A1 | COMPOSITION CONTAINING MICROPARTICLES | CHMP4B, EXOSC10, EXOSC9 | PARP10 3701/4885PARP3 4162/4885ALDH1A1 1737/4885 |
| US-10023540-B2 | Hydrogen barrier agent, hydrogen barrier film forming composition, hydrogen barrier film, method for producing hydrogen barrier film, and electronic element | SLC9A2, SLC9A1, NHERF1 | PARP10 4462/4885PARP3 4535/4885ALDH1A1 3686/4885 |
| US-10570269-B2 | Composition containing microparticles | CHMP4B, EXOSC10, EXOSC9 | PARP10 3701/4885PARP3 4162/4885ALDH1A1 1737/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.